Survival endpoint: pro

Amyotroph Lateral Scler Other Motor Neuron Disord. 2002:3 Suppl 1:S35-6. doi: 10.1080/146608202320374237.
No abstract available

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy
  • Amyotrophic Lateral Sclerosis / mortality*
  • Disease Progression
  • Endpoint Determination / methods*
  • Humans
  • Neuroprotective Agents / therapeutic use
  • Riluzole / therapeutic use
  • Survival*

Substances

  • Neuroprotective Agents
  • Riluzole